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STEMI and NSTEMI, healthcare providers in 
numerous countries, including Poland, recom‑
mended deferral of elective hospitalizations and 
invasive procedures. However, in countries with 
the rapid spread of severe acute respiratory syn‑
drome coronavirus 2 (SARS ‑CoV‑2) and a large 
number of patients with COVID‑19 requiring 
hospitalization, a significant drop in the number 
of cardiac catheterization laboratory activations 
for STEMI has been recently reported.4‑6 None‑
theless, it remains unclear how the COVID‑19 
pandemic has affected the invasive assessment 
and treatment of patients with acute myocar‑
dial infarction (AMI) in countries with a well‑
‑developed network of catheterization laborato‑
ries and a relatively slower spread of SARS ‑CoV‑2, 
such as Poland.
This study aimed to assess the influence of 
the COVID‑19 pandemic on the number of CA 
and PCI procedures in patients with STEMI and 
NSTEMI in selected high ‑volume intervention‑
al cardiology centers in Poland.
Introduction Primary percutaneous coronary 
intervention (PCI) is the preferred reperfusion 
strategy in patients presenting with ST ‑segment 
elevation myocardial infarction (STEMI). An ear‑
ly invasive strategy and revascularization are 
also recommended in patients with non–ST‑
‑segment elevation myocardial infarction 
(NSTEMI).1 In Poland, there are 158 interven‑
tional cardiology centers operating in the 24/7 
mode (approximately 1 center per 240 000 peo‑
ple), and the number of coronary angiographies 
(CAs) and PCI procedures for STEMI and NSTE‑
MI per 1 million population is one of the highest 
in Europe.2 In 2018, the proportion of patients 
with STEMI arriving in the first 12 hours after 
symptom onset who received primary PCI ex‑
ceeded 95%.3
The coronavirus disease 19 (COVID‑19) pan‑
demic significantly influenced healthcare sys‑
tems worldwide. To preserve resources and hos‑
pital beds to care for patients with COVID‑19 
and other life ‑threatening conditions, such as 
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Center for Heart Diseases in Zabrze, Univer‑
sity Hospital in Opole, University Hospital in 
Poznań, the National Institute of Cardiology in 
Warsaw, University Clinical Center in Warsaw, 
Central Clinical Hospital of the Ministry of In‑
terior and Administration in Warsaw, and the 
Medical University of Bialystok Clinical Hospi‑
tal. Data from particular centers were collected 
Methods We retrospectively collected data on 
the number of CA and PCI procedures performed 
between January 1, 2020 and April 14, 2020 in 
11 high ‑volume interventional cardiology cen‑
ters in Poland, including John Paul II Hospital 
in Kraków, New Seat of the University Hospi‑
tal in Kraków, St. Raphael Hospital in Kraków, 
Silesian Medical Center in Katowice, Silesian 
 FIGURE 1 Changes in the total number of coronary procedures with a relative decrease during the COVID‑19 epidemic: A – the number of confirmed SARS ‑CoV‑2 
infections in Poland with the timeline of major lockdown measures; B – the total number of CAs and PCIs performed in the setting of AMI (light red and gray); 
percentage change in the number of procedures as compared with period 0 (dark red and gray); C – the total number of CAs and PCIs performed in the setting of 
STEMI (light red and gray); percentage change in the number of procedures as compared with period 0 (dark red and gray); D – the total number of CAs and PCIs 
performed in the setting of NSTEMI (light red and gray); percentage change in the number of procedures as compared with period 0 (dark red and gray).
 Period 0—from January 1, 2020 to February 29, 2020; period 1—from March 1, 2020 to March 14, 2020; period 2—from March 15, 2020 to March 31, 2020; period 
3—from April 1, 2020 to April 14, 2020
 Abbreviations: AMI, acute myocardial infarction; CA, coronary angiography; COVID‑19, coronavirus disease 19; NSTEMI, non–ST ‑segment elevation myocardial 

























Period 0 Period 1 Period 2 Period 3
































First confirmed case: March 4, 2020



































KARDIOLOGIA POLSKA 2020; 78 (6)576
reported in period 1, and was even more evi‑
dent after epidemic lockdown, which strong‑
ly affected medical operations (periods 2 and 
3). A smaller decrease in the number of STEMI 
procedures can be attributed to a severe symp‑
tomatic course of the disease, forcing patients 
to search medical assistance. On the contrary, 
when symptoms are milder, as in most NSTE‑
MI cases, patients may postpone medical contact 
for fear of infection with SARS‑CoV‑2 in emer‑
gency rooms and other medical facilities. Nev‑
ertheless, this issue requires further research.
Limitations We included 11 high ‑volume cen‑
ters in our study, but we did not cover the entire 
Polish population. The influence of COVID‑19 
on the total number of procedures was clearly 
visible; however, the dynamics of the pandem‑
ic might have differed from region to region, 
and this possible effect was not accounted for 
in our analysis.
Conclusions The COVID‑19 pandemic in Po‑
land is associated with a large decline in the per‑
formance of CA and PCI procedures in the set‑
ting of AMI. The greater decline is observed in 
the number of procedures for NSTEMI than in 
those for STEMI.
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following local reporting procedures. Acute myo‑
cardial infarction (AMI) was defined according 
to the Fourth Universal Definition of Myocar‑
dial Infarction.7 The total number of AMI cases 
was calculated as a sum of STEMIs and NSTE‑
MIs. The approval of an ethics committee was 
not required for this study.
Statistical analysis We evaluated the mean 
2‑week number of CAs and PCIs performed in 
patients with AMI, STEMI, and NSTEMI in 4 dif‑
ferent time periods, selected according to the de‑
velopment of the COVID‑19 pandemic in Poland: 
period 0—from January 1, 2020 to February 29, 
2020 (prepandemic); period 1—from March 1, 
2020 to March 14, 2020 (beginning of the pan‑
demic); period 2—from March 15, 2020 to March 
31, 2020 (gradual introduction of pandemic re‑
strictions); and period 3—from April 1, 2020 
to April 14, 2020 (pandemic lockdown) (FIGURE 1A). 
Finally, we assessed the percentage change in 
the number of CAs and PCIs in AMI, STEMI, and 
NSTEMI in periods 1 to 3 in comparison with pe‑
riod 0 as a prepandemic reference.
Results and discussion Between January 1, 
2020 and April 14, 2020, there were 1898 CAs 
and 1608 PCIs performed in patients with AMI 
in all centers included in the study. In compari‑
son with period 0, we found a slight decrease in 
the number of CA and PCI procedures for AMI 
performed in period 1 (–13.8% and –10.6%, re‑
spectively) as well as a significant decrease in pe‑
riod 2 (–29.2% and –28%, respectively) and peri‑
od 3 (–34.8% and –28.3%, respectively) (FIGURE 1B). 
The percentage drop in the number of CA and PCI 
procedures was more pronounced in patients 
with NSTEMI than in those with STEMI (pe‑
riod 3 vs period 0: CA, –44.3% vs –17.6%, re‑
spectively; PCI, –36.1% vs –16.2%, respective‑
ly) (FIGURE 1C and 1D).
The new COVID‑19 pandemic has a huge im‑
pact on current clinical practice, which is partic‑
ularly notable in the diagnosis and treatment of 
acute coronary syndromes. A recent report has 
shown a decrease of over 39% in admissions 
for acute coronary syndromes after the COV‑
ID‑19 outbreak in Austria.6 Similarly, a 40% 
decline was observed in the number of PCIs 
in STEMI in Spain.5 A report from the United 
States showed a 38% decline in the number of 
catheterization laboratory activations for STEMI 
in 9 high ‑volume centers after the emergence of 
COVID‑19.4 An even greater decline (over 5‑fold) 
in the number of STEMI procedures was report‑
ed in Hong Kong.8 Our study showed consistent 
results, with a decline of around 30% in the num‑
ber of both CAs and PCIs in the setting of AMI 
after the beginning of the COVID‑19 pandem‑
ic in Poland. Similarly to Austria, a decrease 
in the number of procedures occurred just af‑
ter the first identified case of the disease was 
